Received Nov 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | 2TP34 | IM / LL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 3 | MA2488 | IM / LL |
PATIENT CHECKED AFTER 15 MINUTES NO REDNESS. THEN CHECKED AGAIN 5 MINUTES LATER DUE TO TWIN BROTHER HAVING REACTION. REDNESS NOTED AT THE INJECTION SITE FOR BEYFORTUS IN THE RIGHT THIGH AND SPREADING TO GROIN AREA. PATIENT GIVEN 3.4ML OF BENADRYL PO BY STAFF. MONITORED FOR AN ADDITIONAL 25 MINUTES AFTER BENADRYL GIVEN. THE AREA IS IMPROVING AND PATIENT IS DOING WELL.
10/6/25 NASAL CONGESTION, ERYTHEMA OF PHARYNX
NONE
NONE; BEYFORTUS 1ML
NKDA
NONE